• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用过表达文库和深度测序对人凝血酶的无环鉴定适体。

Acyclic identification of aptamers for human alpha-thrombin using over-represented libraries and deep sequencing.

机构信息

Graduate Program in Structural Biology, Biochemistry and Biophysics, Syracuse University, Syracuse, New York, United States of America.

出版信息

PLoS One. 2011;6(5):e19395. doi: 10.1371/journal.pone.0019395. Epub 2011 May 19.

DOI:10.1371/journal.pone.0019395
PMID:21625587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098231/
Abstract

BACKGROUND

Aptamers are oligonucleotides that bind proteins and other targets with high affinity and selectivity. Twenty years ago elements of natural selection were adapted to in vitro selection in order to distinguish aptamers among randomized sequence libraries. The primary bottleneck in traditional aptamer discovery is multiple cycles of in vitro evolution.

METHODOLOGY/PRINCIPAL FINDINGS: We show that over-representation of sequences in aptamer libraries and deep sequencing enables acyclic identification of aptamers. We demonstrated this by isolating a known family of aptamers for human α-thrombin. Aptamers were found within a library containing an average of 56,000 copies of each possible randomized 15mer segment. The high affinity sequences were counted many times above the background in 2-6 million reads. Clustering analysis of sequences with more than 10 counts distinguished two sequence motifs with candidates at high abundance. Motif I contained the previously observed consensus 15mer, Thb1 (46,000 counts), and related variants with mostly G/T substitutions; secondary analysis showed that affinity for thrombin correlated with abundance (K(d) = 12 nM for Thb1). The signal-to-noise ratio for this experiment was roughly 10,000∶1 for Thb1. Motif II was unrelated to Thb1 with the leading candidate (29,000 counts) being a novel aptamer against hexose sugars in the storage and elution buffers for Concanavilin A (K(d) = 0.5 µM for α-methyl-mannoside); ConA was used to immobilize α-thrombin.

CONCLUSIONS/SIGNIFICANCE: Over-representation together with deep sequencing can dramatically shorten the discovery process, distinguish aptamers having a wide range of affinity for the target, allow an exhaustive search of the sequence space within a simplified library, reduce the quantity of the target required, eliminate cycling artifacts, and should allow multiplexing of sequencing experiments and targets.

摘要

背景

适体是与蛋白质和其他靶标具有高亲和力和选择性结合的寡核苷酸。二十年前,人们将自然选择的元素改编为体外选择,以便在随机序列文库中区分适体。传统适体发现的主要瓶颈是多次体外进化循环。

方法/主要发现:我们表明,文库中序列的过度表达和深度测序可以实现无环适体的识别。我们通过分离已知的人α-凝血酶适体家族证明了这一点。在一个文库中发现了适体,该文库平均包含每个可能的随机 15 mer 片段的 56,000 个拷贝。在 2-600 万个读数中,高亲和力序列的计数多次高于背景。对计数超过 10 次的序列进行聚类分析,区分了两个具有高丰度候选物的序列基序。基序 I 包含先前观察到的共识 15mer、Thb1(46,000 个计数)和主要 G/T 取代的相关变体;二次分析表明,与凝血酶的亲和力与丰度相关(Thb1 的 K(d)为 12 nM)。该实验的信噪比约为 10,000∶1 用于 Thb1。基序 II 与 Thb1 无关,主要候选物(29,000 个计数)是针对 Concanavilin A 储存和洗脱缓冲液中六糖的新型适体(α-甲基甘露糖苷的 K(d)为 0.5 µM);ConA 用于固定 α-凝血酶。

结论/意义:过度表达加上深度测序可以大大缩短发现过程,区分对靶标具有广泛亲和力的适体,允许在简化文库中对序列空间进行详尽搜索,减少所需靶标的数量,消除循环伪影,并应允许测序实验和靶标的多重化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/1e005f09b8e2/pone.0019395.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/daf8b90275e2/pone.0019395.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/512fc3634662/pone.0019395.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/ba2ddbbfaedb/pone.0019395.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/bfe70519d967/pone.0019395.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/7f5182261f89/pone.0019395.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/1e005f09b8e2/pone.0019395.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/daf8b90275e2/pone.0019395.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/512fc3634662/pone.0019395.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/ba2ddbbfaedb/pone.0019395.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/bfe70519d967/pone.0019395.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/7f5182261f89/pone.0019395.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08e/3098231/1e005f09b8e2/pone.0019395.g006.jpg

相似文献

1
Acyclic identification of aptamers for human alpha-thrombin using over-represented libraries and deep sequencing.使用过表达文库和深度测序对人凝血酶的无环鉴定适体。
PLoS One. 2011;6(5):e19395. doi: 10.1371/journal.pone.0019395. Epub 2011 May 19.
2
An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.一种用于筛选与化脓性链球菌M11型结合的DNA适配体的改良SELEX技术。
Methods. 2016 Mar 15;97:51-7. doi: 10.1016/j.ymeth.2015.12.005. Epub 2015 Dec 8.
3
Aptamer selection by high-throughput sequencing and informatic analysis.高通量测序和信息学分析的适体选择。
Biotechniques. 2011 Dec;51(6):413-6. doi: 10.2144/000113786.
4
A simple method for eliminating fixed-region interference of aptamer binding during SELEX.一种在指数富集的配体系统进化(SELEX)过程中消除适体结合固定区域干扰的简单方法。
Biotechnol Bioeng. 2014 Nov;111(11):2265-79. doi: 10.1002/bit.25294. Epub 2014 Jul 14.
5
Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.高保真SELEX:一种基于高保真数字PCR的治疗性适配体发现平台。
Biotechnol Bioeng. 2015 Aug;112(8):1506-22. doi: 10.1002/bit.25581.
6
HAPIscreen, a method for high-throughput aptamer identification.HAPIscreen,一种高通量适体鉴定方法。
J Nanobiotechnology. 2011 Jun 3;9:25. doi: 10.1186/1477-3155-9-25.
7
Improvement of Aptamers by High-Throughput Sequencing of Doped-SELEX.高通量测序修饰 SELEX 提高适体的特异性
Methods Mol Biol. 2023;2570:85-102. doi: 10.1007/978-1-0716-2695-5_7.
8
Development, screening, and analysis of DNA aptamer libraries potentially useful for diagnosis and passive immunity of arboviruses.对可能用于虫媒病毒诊断和被动免疫的DNA适配体文库的开发、筛选及分析。
BMC Res Notes. 2012 Nov 13;5:633. doi: 10.1186/1756-0500-5-633.
9
Single-step selection of bivalent aptamers validated by comparison with SELEX using high-throughput sequencing.通过与高通量测序 SELEX 比较验证的二价适体的单步筛选。
PLoS One. 2014 Jun 25;9(6):e100572. doi: 10.1371/journal.pone.0100572. eCollection 2014.
10
Next-Generation Analysis of Deep Sequencing Data: Bringing Light into the Black Box of SELEX Experiments.深度测序数据的下一代分析:揭开SELEX实验黑箱的面纱
Methods Mol Biol. 2016;1380:85-95. doi: 10.1007/978-1-4939-3197-2_7.

引用本文的文献

1
DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design.DAPTEV:用于 COVID-19 药物设计的深度适体进化建模。
PLoS Comput Biol. 2023 Jul 5;19(7):e1010774. doi: 10.1371/journal.pcbi.1010774. eCollection 2023 Jul.
2
Pushing the Limits of Nucleic Acid Function.推动核酸功能的极限。
Chemistry. 2022 Dec 20;28(71):e202201737. doi: 10.1002/chem.202201737. Epub 2022 Oct 26.
3
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.针对淀粉样蛋白的适体及其在神经退行性疾病中的新兴作用。

本文引用的文献

1
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.通过微流控选择和高通量测序进行 DNA 适体的定量选择。
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15373-8. doi: 10.1073/pnas.1009331107. Epub 2010 Aug 12.
2
Aptamers as therapeutics.适配子疗法。
Nat Rev Drug Discov. 2010 Jul;9(7):537-50. doi: 10.1038/nrd3141.
3
Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX.在 SELEX 过程中使用高通量测序监测基因组序列:中性 SELEX。
J Biol Chem. 2022 Jan;298(1):101478. doi: 10.1016/j.jbc.2021.101478. Epub 2021 Dec 9.
4
Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer.用于卵巢癌的波形蛋白结合适体基序的选择和表征。
Molecules. 2021 Oct 28;26(21):6525. doi: 10.3390/molecules26216525.
5
Single-round deoxyribozyme discovery.单轮脱氧核酶发现
Nucleic Acids Res. 2021 Jul 9;49(12):6971-6981. doi: 10.1093/nar/gkab504.
6
Implementation of High-Throughput Sequencing (HTS) in Aptamer Selection Technology.高通量测序(HTS)在适体筛选技术中的应用
Int J Mol Sci. 2020 Nov 20;21(22):8774. doi: 10.3390/ijms21228774.
7
RaptRanker: in silico RNA aptamer selection from HT-SELEX experiment based on local sequence and structure information.RaptRanker:基于局部序列和结构信息的 HT-SELEX 实验中 RNA 适体的计算选择。
Nucleic Acids Res. 2020 Aug 20;48(14):e82. doi: 10.1093/nar/gkaa484.
8
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.适配体:治疗应用的化学性质和修饰的综述。
Molecules. 2019 Nov 21;24(23):4229. doi: 10.3390/molecules24234229.
9
Aptamer Selection Technology and Recent Advances.适配体筛选技术及最新进展
Mol Ther Nucleic Acids. 2015;4(1):e223. doi: 10.1038/mtna.2014.74. Epub 2016 Dec 6.
10
Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers.高通量测序在适体的体外筛选与表征中的应用
Pharmaceuticals (Basel). 2016 Dec 10;9(4):76. doi: 10.3390/ph9040076.
PLoS One. 2010 Feb 11;5(2):e9169. doi: 10.1371/journal.pone.0009169.
4
Analysis of aptamer sequence activity relationships.分析适体序列的活性关系。
Integr Biol (Camb). 2009 Jan;1(1):116-22. doi: 10.1039/b814892a. Epub 2008 Nov 12.
5
Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells.用于富集、分选和检测多种癌细胞的基于适配体的微流控装置。
Anal Chem. 2009 Sep 1;81(17):7436-42. doi: 10.1021/ac9012072.
6
Micromagnetic selection of aptamers in microfluidic channels.微流控通道中适体的微磁选择
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):2989-94. doi: 10.1073/pnas.0813135106. Epub 2009 Feb 6.
7
Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei.针对类鼻疽伯克霍尔德菌潜在诊断靶点的适配体的开发。
Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1(0 1):S55-7. doi: 10.1016/S0035-9203(08)70015-4.
8
In vitro selection and characterization of cellulose-binding DNA aptamers.纤维素结合DNA适体的体外筛选与表征
Nucleic Acids Res. 2007;35(19):6378-88. doi: 10.1093/nar/gkm708. Epub 2007 Sep 18.
9
Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.生物技术、诊断和治疗中的功能性适体与核酸酶。
Chem Rev. 2007 Sep;107(9):3715-43. doi: 10.1021/cr0306743. Epub 2007 Aug 23.
10
One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX.通过单链寡核苷酸指数富集系统一步筛选痘苗病毒结合DNA适配体
BMC Biotechnol. 2007 Aug 15;7:48. doi: 10.1186/1472-6750-7-48.